A functional genomics approach to identify pathways of drug resistance in medulloblastoma

被引：11
|
作者：
Bertrand, Kelsey C. [1 ,2 ,3 ]
Faria, Claudia C. [4 ]
Skowron, Patryk [5 ,6 ,7 ,8 ]
Luck, Amanda [5 ,6 ,7 ,8 ]
Garzia, Livia [5 ,6 ,7 ,8 ]
Wu, Xiaochong [5 ,6 ,7 ,8 ]
Agnihotri, Sameer [9 ]
Smith, Christian A. [5 ,6 ,7 ,8 ]
Taylor, Michael D. [5 ,6 ,7 ,8 ]
Mack, Stephen C. [1 ,2 ,3 ]
Rutka, James T. [5 ,6 ,7 ,8 ]
机构：
[1] Baylor Coll Med, Dept Pediat, Div Hematol & Oncol, Houston, TX 77030 USA
[2] Texas Childrens Hosp, Canc Ctr, Brain Tumor Program, Houston, TX 77030 USA
[3] Texas Childrens Hosp, Hematol Ctr, Brain Tumor Program, Houston, TX 77030 USA
[4] Ctr Hosp Lisboa Norte, Hosp Santa Maria, Dept Neurosurg, EPE, Lisbon, Portugal
[5] Hosp Sick Children, Dept Dev & Stem Cell Biol & Regenerat Med, Toronto, ON, Canada
[6] Hosp Sick Children, Arthur & Sonia Labatt Brain Tumor Res Ctr, Toronto, ON, Canada
[7] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada
[8] Hosp Sick Children, Dept Neurosurg, Toronto, ON, Canada
[9] Univ Pittsburgh, Childrens Hosp, Sch Med, Dept Neurol Surg, Pittsburgh, PA 15260 USA
来源：
ACTA NEUROPATHOLOGICA COMMUNICATIONS | 2018年 / 6卷
基金：
美国国家卫生研究院;
关键词：
Cancer; Brain tumor; Medulloblastoma; Drug resistance; Functional genomics; Transposon mutagenesis; Sleeping beauty; MOLECULAR SUBGROUPS; LANDSCAPE; MUTATIONS; ACVR1;
D O I：
10.1186/s40478-018-0652-8
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
引用
收藏
页数：6
相关论文
共 50 条
  • [41] Drug Repurposing Approach to Identify Candidate Drug Molecules for Hepatocellular Carcinoma
    Baser, Tugce
    Rifaioglu, Ahmet Sureyya
    Atalay, Mehmet Volkan
    Atalay, Rengul Cetin
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (17)
  • [42] Targeting feedback activation of signaling transduction pathways to overcome drug resistance in cancer
    Wang, Xuejian
    Jiang, Wenyan
    Du, Yanmei
    Zhu, Dongqi
    Zhang, Jian
    Fang, Chunyan
    Yan, Fang
    Chen, Zhe-Sheng
    DRUG RESISTANCE UPDATES, 2022, 65
  • [43] A comprehension of signaling pathways and drug resistance; an insight into the correlation between microRNAs and cancer
    Alsaab, Hashem O.
    Abdullaev, Bekhzod
    Alkhafaji, Adnan Taan
    Alawadi, Ahmed Hussien
    Jahlan, Ibtesam
    Bahir, Hala
    Bisht, Yashwant Singh
    Alsaalamy, Ali
    Jabbar, Abeer Mhussan
    Mustafa, Yasser Fakri
    PATHOLOGY RESEARCH AND PRACTICE, 2023, 251
  • [44] LncRNAs driving feedback loops to boost drug resistance: sinuous pathways in cancer
    Sanchez-Marin, David
    Trujano-Camacho, Samuel
    Perez-Plasencia, Carlos
    Cantu De Leon, David
    Campos-Parra, Alma D.
    CANCER LETTERS, 2022, 543
  • [45] Accuracy of an amplicon-sequencing nanopore approach to identify variants in tuberculosis drug-resistance-associated genes
    Mariner-Llicer, Carla
    Goig, Galo A.
    Zaragoza-Infante, Laura
    Torres-Puente, Manuela
    Villamayor, Luis
    Navarro, David
    Borras, Rafael
    Chiner-Oms, Alvaro
    Comas, Inaki
    MICROBIAL GENOMICS, 2021, 7 (12):
  • [46] Utilising the EGFR interactome to identify mechanisms of drug resistance in non-small cell lung cancer - Proof of concept towards a systems pharmacology approach
    Saafan, Hisham
    Foerster, Sarah
    Parra-Guillen, Zinnia P.
    Hammer, Elke
    Michaelis, Martin
    Cinatl, Jindrich, Jr.
    Voelker, Uwe
    Froehlich, Holger
    Kloft, Charlotte
    Ritter, Christoph A.
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2016, 94 : 20 - 32
  • [47] A functional genomics approach using metabolomics and in silico pathway analysis
    Förster, J
    Gombert, AK
    Nielsen, J
    BIOTECHNOLOGY AND BIOENGINEERING, 2002, 79 (07) : 703 - 712
  • [48] Targeting senescence pathways to reverse drug resistance in cancer
    Rebbaa, A
    CANCER LETTERS, 2005, 219 (01) : 1 - 13
  • [49] New approach to acquired drug resistance and toxicity in cancer chemotherapy
    Kolodny, Gerald M.
    MEDICAL HYPOTHESES, 2024, 184
  • [50] Signalling Pathways in Anti-cancer Drug Resistance
    Chen, Chen
    Chen, Jiezhong
    Zhao, Kong-Nan
    CURRENT MEDICINAL CHEMISTRY, 2014, 21 (26) : 3007 - 3008
12345